Year: 2026
Type: article
Abstract: Introduction: The diagnostic accuracy of phenotype-matching tools for rare diseases depends not only on the algorithm but also on the quality of the disease definitions. Inherited kidney diseases (IKDs) pose a significant challenge for clinical diagnosis due to substantial phenotypic overlap and heterogeneity, but many patients remain undiagnosed despite growing access to genetic testing. This study assesses whether an expert-curated, IKD-specific database (CURATED) provides a closer phenotypic match to real patients than the Mondo Disease Ontology (MONDO), a broad, general-purpose resource. Methods: Using a cohort of 340 real-world patients with genetically confirmed diagnoses across 8 IKD categories, we compared MONDO- and CURATED-based disease definitions across 3 independent, computational phenotype-matching tools (Phenomizer, Phrank, and Phen2Disease), which match Human Phenotype Ontology (HPO)-annotated patient phenotypes to disease profiles, using similarity scoring, diagnostic ranking, and mixed-effects models accounting for disease imbalance and interannotator variability. Results: With CURATED definitions, similarity scores rose by 18%-30% and Discounted Cumulative Gain (DCG) improved by 15%-37% relative to MONDO, reflecting a stronger tendency across all 3 tools to place the correct diagnosis at or near the top of the ranked list. These improvements were maintained after mixed-effects modeling. Conclusion: The quality of the underlying disease database can be as consequential as the choice of diagnostic algorithm. In this cohort, domain-specific curation improved diagnostic prioritization, suggesting that investment in high-quality, nephrology-specific phenotype resources may advance IKD diagnosis as much as further algorithmic refinement.
Source: Kidney International Reports
Institutions: Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, Institut de Recerca Sant Joan de Déu, Universitat Politècnica de Catalunya, Universitat Autònoma de Barcelona, Hospital de Sant Pau, Puigvert Foundation, Institut de Recerca Sant Pau, Hospital Sant Joan de Déu Barcelona
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,800
Funders: Fundació la Marató de TV3, Centres de Recerca de Catalunya, European Commission, Generalitat de Catalunya, Ministerio de Economía y Competitividad, Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Universitätsklinikum Köln, Instituto de Salud Carlos III, Agencia Estatal de Investigación
Awards: G1652358158, G7284396075
OpenAlex ID: W7214405598
